Sadat Razavi Zahra, Sina Alizadeh Seyed, Sadat Razavi Fateme, Souri Mohammad, Soltani M
Physiology Research Center, Iran University Medical Sciences, Tehran, Iran; Department of Mechanical Engineering, K. N. Toosi University of Technology, Tehran, Iran.
Department of Chemistry, K.N. Toosi University of Technology, Tehran, Iran.
Int J Pharm. 2025 Feb 10;670:125186. doi: 10.1016/j.ijpharm.2025.125186. Epub 2025 Jan 7.
The blood-brain barrier (BBB) plays a vital role in protecting the central nervous system (CNS) by preventing the entry of harmful pathogens from the bloodstream. However, this barrier also presents a significant obstacle when it comes to delivering drugs for the treatment of neurodegenerative diseases and brain cancer. Recent breakthroughs in nanotechnology have paved the way for the creation of a wide range of nanoparticles (NPs) that can serve as carriers for diagnosis and therapy. Regarding their promising properties, organic NPs have the potential to be used as effective carriers for drug delivery across the BBB based on recent advancements. These remarkable NPs have the ability to penetrate the BBB using various mechanisms. This review offers a comprehensive examination of the intricate structure and distinct properties of the BBB, emphasizing its crucial function in preserving brain balance and regulating the transport of ions and molecules. The disruption of the BBB in conditions such as stroke, Alzheimer's disease, and Parkinson's disease highlights the importance of developing creative approaches for delivering drugs. Through the encapsulation of therapeutic molecules and the precise targeting of transport processes in the brain vasculature, organic NP formulations present a hopeful strategy to improve drug transport across the BBB. We explore the changes in properties of the BBB in various pathological conditions and investigate the factors that affect the successful delivery of organic NPs into the brain. In addition, we explore the most promising delivery systems associated with NPs that have shown positive results in treating neurodegenerative and ischemic disorders. This review opens up new possibilities for nanotechnology-based therapies in cerebral diseases.
血脑屏障(BBB)通过阻止有害病原体从血液进入,在保护中枢神经系统(CNS)方面发挥着至关重要的作用。然而,在递送用于治疗神经退行性疾病和脑癌的药物时,这一屏障也构成了重大障碍。纳米技术的最新突破为创建多种可作为诊断和治疗载体的纳米颗粒(NPs)铺平了道路。鉴于其有前景的特性,基于最近的进展,有机 NPs 有潜力被用作跨越血脑屏障进行药物递送的有效载体。这些卓越的 NPs 能够通过各种机制穿透血脑屏障。本综述全面考察了血脑屏障的复杂结构和独特性质,强调了其在维持脑平衡以及调节离子和分子运输方面的关键作用。在中风、阿尔茨海默病和帕金森病等病症中血脑屏障的破坏凸显了开发创新药物递送方法的重要性。通过封装治疗性分子以及精确靶向脑血管系统中的运输过程,有机 NP 制剂为改善药物跨越血脑屏障的运输提供了一种有希望的策略。我们探讨了在各种病理条件下血脑屏障性质的变化,并研究了影响有机 NPs 成功递送至脑内的因素。此外,我们还探讨了与 NPs 相关的、在治疗神经退行性和缺血性疾病方面已显示出积极效果的最有前景的递送系统。本综述为基于纳米技术的脑部疾病治疗开辟了新的可能性。